Stock V3V VITA 34 AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials VITA 34 AG

Equities

V3V

DE000A0BL849

Healthcare Facilities & Services

Real-time Estimate Tradegate
Other stock markets
 09:30:00 2024-05-03 am EDT 		5-day change 1st Jan Change
4.72 EUR -0.84% Intraday chart for VITA 34 AG -7.72% -11.07%
2023 VITA 34 AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 VITA 34 AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 52.07 51.43 239.8 123.8 82.94 82.97 - -
Enterprise Value (EV) 1 50.25 46.34 239 135.7 82.94 89.57 84.37 82.97
P/E ratio 38.6 x 33.9 x -23.8 x -4.57 x -43.7 x -39.7 x -52.9 x -
Yield 1.25% - - - - - - -
Capitalization / Revenue 2.57 x 2.56 x 8.44 x 1.8 x 1.08 x 1.05 x 1.02 x 0.99 x
EV / Revenue 2.48 x 2.31 x 8.41 x 1.97 x 1.08 x 1.13 x 1.04 x 0.99 x
EV / EBITDA 8.75 x 7.99 x 294 x -38.1 x 14.9 x 15.2 x 12.2 x -
EV / FCF 10.2 x 13.9 x 512 x -12.4 x - 16.3 x 16.5 x -
FCF Yield 9.79% 7.2% 0.2% -8.05% - 6.14% 6.04% -
Price to Book 1.73 x 1.74 x 2.03 x 7.5 x - - - -
Nbr of stocks (in thousands) 4,084 4,098 15,989 15,828 15,828 17,432 - -
Reference price 2 12.75 12.55 15.00 7.820 5.240 4.760 4.760 4.760
Announcement Date 3/23/20 3/30/21 4/30/22 4/30/23 4/30/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 20.25 20.07 28.42 68.94 77.06 79.1 81.5 83.9
EBITDA 1 5.746 5.8 0.814 -3.564 5.569 5.9 6.9 -
EBIT 1 3.282 2.88 -3.071 -27.28 -3.12 -2 -1.1 -
Operating Margin 16.21% 14.35% -10.81% -39.57% -4.05% -2.53% -1.35% -
Earnings before Tax (EBT) 1 3.142 2.27 -3.447 -28.29 -4.342 -3 -2.1 -
Net income 1 1.35 1.151 -3.667 -27.09 -1.865 -2.2 -1.5 -
Net margin 6.67% 5.74% -12.9% -39.29% -2.42% -2.78% -1.84% -
EPS 2 0.3300 0.3700 -0.6300 -1.710 -0.1200 -0.1200 -0.0900 -
Free Cash Flow 1 4.918 3.335 0.467 -10.92 - 5.5 5.1 -
FCF margin 24.29% 16.62% 1.64% -15.84% - 6.95% 6.26% -
FCF Conversion (EBITDA) 85.59% 57.5% 57.37% - - 93.22% 73.91% -
FCF Conversion (Net income) 364.3% 289.75% - - - - - -
Dividend per Share 0.1600 - - - - - - -
Announcement Date 3/23/20 3/30/21 4/30/22 4/30/23 4/30/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S1 2022 Q1 2022 Q2 2022 S1
Net sales 1 9.768 - 16.63 32.11
EBITDA 1 2.789 - -1.549 -2.613
EBIT - - - -
Operating Margin - - - -
Earnings before Tax (EBT) - - - -
Net income - -2.81 - -
Net margin - - - -
EPS - -0.1800 - -
Dividend per Share - - - -
Announcement Date 8/29/19 5/31/22 8/30/22 8/30/22
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 11.9 - 6.6 1.4 -
Net Cash position 1 1.82 5.09 0.86 - - - - -
Leverage (Debt/EBITDA) - - - -3.339 x - 1.119 x 0.2029 x -
Free Cash Flow 1 4.92 3.34 0.47 -10.9 - 5.5 5.1 -
ROE (net income / shareholders' equity) 4.53% 4% -10.6% -90.9% - -12% -9.4% -
ROA (Net income/ Total Assets) 2.24% 1.96% -3.1% -16.4% - -1.4% -1% -
Assets 1 60.21 58.62 118.3 164.7 - 157.1 150 -
Book Value Per Share 7.360 7.210 7.400 1.040 - - - -
Cash Flow per Share - - - - - - - -
Capex 1 1.4 0.65 2.26 6.43 - 2 2.5 2.5
Capex / Sales 6.91% 3.21% 7.95% 9.33% - 2.53% 3.07% 2.98%
Announcement Date 3/23/20 3/30/21 4/30/22 4/30/23 4/30/24 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for VITA 34 AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.76 EUR
Average target price
5.3 EUR
Spread / Average Target
+11.34%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
VITA 34 AG Stock VITA 34 AG
-11.07% 88.77M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.10% 81.68B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-30.15% 69.23B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.37% 29.08B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.90% 16.88B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
0.00% 16.85B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-1.12% 15.15B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.87% 12.62B
DAVITA INC. Stock DaVita Inc.
+35.78% 12.47B
PURE HEALTH HOLDING Stock Pure Health Holding
-30.70% 11.89B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. V3V Stock
  4. Financials VITA 34 AG